Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

  • STATUS
    Recruiting
  • End date
    Dec 23, 2023
  • participants needed
    112
  • sponsor
    Fudan University
Updated on 14 February 2022
liver cancer
cancer
lamivudine
antiviral drugs

Summary

Evaluation the Treatment Outcome of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery.

Description

The investigators conduct this clinical trial to evaluate the treatment outcome of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery.The primary outcome is overall survival and objective response rate.

Details
Condition Hepatocellular Carcinoma, Recurrence
Treatment Aspirin, lamivudine
Clinical Study IdentifierNCT01936233
SponsorFudan University
Last Modified on14 February 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Hepatocellular carcinoma confirmed with pathology or identified with radiological images with typical features
Age 18 years and 75 years
At least one tumor nodule with one uni-dimension of 2 cm
Child-Pugh Class A or B
HBV-DNA>10^4
Total bilirubin 1.5 x upper limit of normal
ALT and AST 2.0 x the upper limit of normal
PT-INR<2.3,PTT < 1.5 x upper limit of normal
Serum creatinine 1.5x upper limit of normal
Peripheral white blood cell count of or more than 310(9)/L
Peripheral platelet of or more than 5010(9)/L
Expected survival time not less than 3 months
ECOG score 0-2

Exclusion Criteria

Tumor thrombi in main branch of portal vein
Tumor involvement more than 70% of whole liver
With extrahepatic metastasis
Prior systemic chemotherapy or chemoembolization
Congestive heart failure > NYHA class 2
History of HIV infection
Active clinically serious infections (> 2 NCI-CTC Version 3.0)
Recurrence of HCC after liver transplantation
Pregnant or breast-feeding
Substance abuse, medical, psychological or social conditions that may interfere with the patient's participation in this study
Known or suspected allergy to any agent given in association with this trial
Patients unable to swallow oral medication
Inclined to thrombosis
Inclined to hemorrhage or active hemorrhage with 1 month
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note